Mitochondrial Infusions Given to Babies with Heart Damage

Among 11 infants treated to date, most survived and their heart function improved.

Written byKerry Grens
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Eleven babies have been given an experimental treatment to repair damaged heart tissue: 1 billion of their own mitochondria infused into the impaired cardiac muscle. So far, The New York Times reports, eight babies have survived and their hearts are working better; in comparison, 65 percent of similar babies who don’t receive the treatment die and none experience an improvement in their cardiac function.

“They gave her a fighting chance,” Kate Bowen, the mother of one of the babies who was treated, tells The Times. Her daughter Georgia went into cardiac arrest after birth and was kept alive with a machine that operated her lungs and heart. She can now breathe on her own, although her heart has not fully recovered.

Mitochondrial transplants come from the patients’ own healthy cells in another part of the body. They are then isolated and delivered to the heart.

Doctors who developed the technique ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026, Issue 1

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Skip the Wait for Protein Stability Data with Aunty

Skip the Wait for Protein Stability Data with Aunty

Unchained Labs
Graphic of three DNA helices in various colors

An Automated DNA-to-Data Framework for Production-Scale Sequencing

illumina

Products

nuclera logo

Nuclera eProtein Discovery System installed at leading Universities in Taiwan

Brandtech Logo

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Logo

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Colorful abstract spiral dot pattern on a black background

Thermo Scientific X and S Series General Purpose Centrifuges

Thermo Fisher Logo